SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-063099
Filing Date
2021-05-07
Accepted
2021-05-07 16:18:47
Documents
1
Group Members
5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM PARTNERS V, LLCANDREW J. SCHWABDR. KUSH PARMARDR. SCOTT M. ROCKLAGE

Document Format Files

Seq Description Document Type Size
1 SC 13G a21-15508_1sc13g.htm SC 13G 273505
  Complete submission text file 0001104659-21-063099.txt   275217
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Subject) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92517 | Film No.: 21902954
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 SAND HILL ROAD, SUITE 110 MENLO PARK CA 94025
Business Address 2200 SAND HILL ROAD, SUITE 110 MENLO PARK CA 94025 (650) 233-8600
5AM Ventures V, L.P. (Filed by) CIK: 0001674324 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G